← Pacira BioSciences, Inc.

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net Income (Loss) Attributable to Parent ($37.9m) ($42.6m) ($471k) ($11.0m) $145.5m $42.0m $15.9m $42.0m ($99.6m) $7.0m
Depreciation, Depletion and Amortization $12.9m $13.8m $13.2m $19.6m $19.9m $28.5m $91.5m $75.6m $78.8m $91.0m
Depreciation $12.8m $13.8m $13.2m $14.0m $12.0m $15.0m $34.2m $18.3m $21.5m $33.7m
Amortization of Debt Issuance Costs — — — — $2.2m $2.8m $4.4m $3.0m $3.1m $2.8m
Amortization of Debt Issuance Costs and Discounts — — — — — — — $3.7m $3.2m $3.0m
Amortization of Intangible Assets $100k $0 $13.2m $5.7m $7.9m $13.6m $57.3m $57.3m $57.3m $57.3m
Deferred Income Tax Expense (Benefit) — — — ($1.8m) ($126.6m) $10.9m ($7.9m) $15.6m $20.6m $6.5m
Share-based Payment Arrangement, Noncash Expense $31.2m $31.6m $31.7m $33.6m $39.9m $42.2m $48.1m $47.9m $51.2m $57.5m
Payment, Tax Withholding, Share-based Payment Arrangement — — — — — — — $106k $491k $5.6m
Share-based Payment Arrangement, Expense $31.2m $31.6m $31.7m $33.6m $39.9m $42.2m $48.1m $47.9m $51.2m $57.5m
Equity Method Investment, Other than Temporary Impairment — — — — — — $10.0m $0 $0 $11.0m
Goodwill, Impairment Loss — — — — — — — — $163.2m $0
Impairment of Intangible Assets (Excluding Goodwill) — — — — — — — — — $25.9m
Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) — — — — $0 $0 $26.1m $0 $0 $25.9m
Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property ($389k) ($2.1m) ($65k) ($1.0m) ($22k) $10k ($193k) — — —
Gain (Loss) on Extinguishment of Debt $0 ($3.7m) $0 $0 ($8.1m) $0 $0 ($16.9m) $7.5m ($983k)
Income Tax Expense (Benefit) $105k $140k $46k $268k ($125.4m) $14.4m ($2.6m) $19.7m $36.5m $9.8m
Interest Expense Nonoperating — — — — — — — — $16.6m $17.4m
Other Nonoperating Income (Expense) ($82k) $167k ($888k) ($5.0m) $2.9m ($2.7m) ($11.3m) ($186k) ($373k) ($6.6m)
Changes in operating assets and liabilities:
Additional Financial Items
Increase (Decrease) in Accounts Receivable $4.1m $1.7m $6.0m $8.5m $5.5m $10.4m $2.1m $7.2m $7.7m $10.7m
Increase (Decrease) in Inventories ($30.4m) $10.1m $7.2m $8.0m $6.4m $4.5m ($2.5m) $8.3m $20.9m $27.6m
Increase (Decrease) in Accounts Payable — — ($573k) ($1.8m) ($3.3m) ($10.3m) $6.3m $916k $3.1m ($5.6m)
Proceeds from Stock Options Exercised $5.8m $6.8m $7.2m $8.5m $45.2m $23.8m $24.4m $1.9m $0 $502k
Asset Retirement Obligation, Accretion Expense — $100k $100k $200k $100k — — — — —
Gain (Loss) on Investments — — ($854k) ($4.3m) $1.6m ($2.7m) — — — —
Gain (Loss) on Termination of Lease — — — — — — — — ($2.2m) $0
Goodwill $46.7m $55.2m $62.0m $99.5m $99.5m $145.2m $163.2m $163.2m $0 $20.2m
Investment Income, Interest $1.3m $4.1m $6.5m $7.4m $4.6m $896k $4.5m $11.4m $19.7m $22.7m
Litigation Settlement Loss — — — — — — — — — $7.0m
Nonoperating Income (Expense) ($5.8m) ($17.5m) ($16.3m) ($21.2m) ($26.3m) ($33.5m) ($46.7m) ($26.0m) — ($2.3m)
Operating Expenses $308.4m $311.6m $321.4m $410.5m — — — — — —
Realized Investment Gains (Losses) — — $900k — — — — — — —
Unrealized Gain (Loss) on Investments — — — $5.7m — — — — — —
Net Cash Provided by (Used in) Operating Activities $33.5m $17.8m $48.9m $70.5m $77.0m $125.7m $145.3m $154.6m $189.4m $152.0m
Cash flows from investing activities:
Payments to Acquire Property, Plant, and Equipment $24.7m $19.3m $14.5m $10.2m $37.8m $45.9m $30.1m $15.2m $10.6m $15.3m
Payments to Acquire Businesses, Net of Cash Acquired — — — $117.7m $0 $0 — $0 — $16.7m
Payments to Acquire Investments $192.8m $502.8m $363.3m $318.5m $546.5m — — — — —
Net Cash Provided by (Used in) Investing Activities ($61.8m) ($223.8m) $20.6m ($128.5m) ($277.6m) ($20.8m) ($225.2m) $77.5m ($83.3m) $99.5m
Cash flows from financing activities:
Proceeds from Issuance of Long-term Debt ($4k) — — — — — — — — —
Payments for Repurchase of Common Stock — — — — — — — — $25.0m $148.3m
Net Cash Provided by (Used in) Financing Activities $7.3m $224.2m $9.0m $3.7m $222.3m $380.7m ($401.5m) ($183.0m) $17.4m ($369.6m)
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents — — — — — — — $0 $0 ($77k)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect — — — — $21.7m $485.6m ($481.4m) $49.2m $123.5m ($118.2m)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents — — — — — — $104.1m $153.3m $276.8m $158.5m
Supplemental disclosure of cash flow information:
Interest Paid, Excluding Capitalized Interest, Operating Activities $3.9m $6.9m $8.2m $8.2m $7.2m $7.0m $33.3m $27.6m $15.4m $15.2m
Income Taxes Paid, Net — — — — — — — — — $9.0m

Data sourced from SEC EDGAR 10-K filings via EdgarTools. Amounts are shown in USD as reported in each fiscal year filing.